Tafenoquine: WHO awards prequalification to single-dose medicine for P. vivax malaria Ruchika Sharma5 Dec 2024 12:30 PM ISTLondon: GSK plc and Medicines for Malaria Venture (MMV) has announced that the World Health Organization (WHO) has awarded prequalification to...
GSK Gets CDSCO Panel Nod to Study antimalarial drug Tafenoquine Dr. Divya Colin24 April 2024 6:00 PM ISTNew Delhi: The pharmaceutical major GSK has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Tafenoquine- Higher dose would reduce Malaria recurrence Dr. Kamal Kant Kohli2 Dec 2022 8:00 PM ISTA new antimalarial drug is being introduced at a dose that is too low to be effective for all patients who need it, according to a report published...
Australia approves Single-dose Kozenis for malaria in children MD Bureau18 March 2022 2:45 PM ISTKozenis is a single-dose treatment for the prevention of relapse of P. vivax and was approved for people aged 16 years and older by the TGA in 2018....
Present clinical trial, pharmacokinetic data of antiparasitic drug Tafenoquine: CDSCO panel tells GSK Medical Dialogues Team31 July 2021 10:30 AM ISTNew Delhi: Seeking justification for Phase III Clinical Trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
